1,040
Views
11
CrossRef citations to date
0
Altmetric
Review

Recent progress in protein-protein interaction study for EGFR-targeted therapeutics

&
Pages 817-832 | Received 28 Apr 2016, Accepted 08 Jul 2016, Published online: 29 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jafar Sharifi, Mohammad Reza Khirehgesh, Fatemeh Safari & Bahman Akbari. (2021) EGFR and anti-EGFR nanobodies: review and update. Journal of Drug Targeting 29:4, pages 387-402.
Read now

Articles from other publishers (10)

Wenjing Huang, Li Wang, Hao Zhang, Zhihao Han & Yueqing Gu. (2023) Near-infrared targeted EGFR fluorescent probe for tumor imaging and diagnosis. Sensors and Actuators B: Chemical 393, pages 134102.
Crossref
Lennard Karsten, Lukas Goett-Zink, Julian Schmitz, Raimund Hoffrogge, Alexander Grünberger, Tilman Kottke & Kristian M. Müller. (2022) Genetically Encoded Ratiometric pH Sensors for the Measurement of Intra- and Extracellular pH and Internalization Rates. Biosensors 12:5, pages 271.
Crossref
Lennard Karsten, Nils Janson, Vadim Le Joncour, Sarfaraz Alam, Benjamin Müller, Jayendrakishore Tanjore Ramanathan, Pirjo Laakkonen, Norbert Sewald & Kristian M. Müller. (2022) Bivalent EGFR-Targeting DARPin-MMAE Conjugates. International Journal of Molecular Sciences 23:5, pages 2468.
Crossref
Mareile Boschanski, Tobias Krüger, Lennard Karsten, Georg Falck, Sarfaraz Alam, Marcus Gerlach, Benjamin Müller, Kristian M. Müller, Norbert Sewald & Thomas Dierks. (2021) Site-Specific Conjugation Strategy for Dual Antibody–Drug Conjugates Using Aerobic Formylglycine-Generating Enzymes. Bioconjugate Chemistry 32:6, pages 1167-1174.
Crossref
Jafar Sharifi, Mohammad Reza Khirehgesh, Bahman Akbari, Bijan Soleymani & Kamran Mansouri. (2021) Paper Title “Hu7CG2: A Novel Humanized Anti-Epidermal Growth Factor Receptor (EGFR) Biparatopic Nanobody”. Molecular Biotechnology 63:6, pages 525-533.
Crossref
Xi Xi, Weihan Sun, Hang Su, Xitian Zhang & Fei Sun. (2020) Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking. Molecular Immunology 128, pages 165-174.
Crossref
Xiangqi Meng, Yu Zhao, Bo Han, Caijun Zha, Yangong Zhang, Ziwei Li, Pengfei Wu, Tengfei Qi, Chuanlu Jiang, Yang Liu & Jinquan Cai. (2020) Dual functionalized brain-targeting nanoinhibitors restrain temozolomide-resistant glioma via attenuating EGFR and MET signaling pathways. Nature Communications 11:1.
Crossref
Rebecca C. Feiner, Julian Teschner, Kathrin E. Teschner, Marco T. Radukic, Tobias Baumann, Sven Hagen, Yvonne Hannappel, Niklas Biere, Dario Anselmetti, Katja M. Arndt & Kristian M. Müller. (2019) rAAV Engineering for Capsid-Protein Enzyme Insertions and Mosaicism Reveals Resilience to Mutational, Structural and Thermal Perturbations. International Journal of Molecular Sciences 20:22, pages 5702.
Crossref
Rebecca C. Feiner, Ina Pennè, Benjamin Müller & Kristian M. Müller. (2019) EGF-mCherry Fusion Protein Expressed in E. coli Shows Product Heterogeneity but a High Biological Activity . Biochemistry 58:8, pages 1043-1047.
Crossref
Armand G. Ngounou Wetie, Izabela Sokolowska, Devika Channaveerappa, Emmalyn J. Dupree, Madhuri Jayathirtha, Alisa G. Woods & Costel C. Darie. 2019. Advancements of Mass Spectrometry in Biomedical Research. Advancements of Mass Spectrometry in Biomedical Research 121 142 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.